Erwin Goetschi

A New DNA Gyrase Inhibitor Subclass of the Cyclothialidine Family Based on a Bicyclic Dilactam−Lactone Scaffold. Synthesis and Antibacterial Properties

Peter Angehrn, Erwin Goetschi, Hans Gmuender et al. · Journal of Medicinal Chemistry · 2011 · 68 citations

Antimicrobial Chemotherapy, Bicyclic Dilactam−lactone Scaffold, Pharmaceutical Chemistry +17

Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder

Patrick Schnider, Caterina Bissantz, Andreas Bruns et al. · Journal of Medicinal Chemistry · 2020 · 60 citations

New Antibacterial Agents Derived from the DNA Gyrase Inhibitor Cyclothialidine

Peter Angehrn, Stefan Buchmann, Christoph Funk et al. · Journal of Medicinal Chemistry · 2004 · 55 citations

Molecular Biology, Antimicrobial Chemotherapy, Chemical Biology +18

Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists

Thomas J. Woltering, Jürgen Wichmann, Erwin Goetschi et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 38 citations · Full text

Medicinal Chemistry, Biochemistry, Vivo Active Potent +11

Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists

Thomas J. Woltering, Jürgen Wichmann, Erwin Goetschi et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 18 citations · Full text

Molecular Pharmacology, Biochemistry, Functional Selectivity +8